Broadridge Announces CFO Transition
Get Alerts BR Hot Sheet
Join SI Premium – FREE
"I want to thank Edmund for his strong contributions and leadership over the past four years. He has been a valuable partner, and I wish him continued success in his next role," said
"As CFO of our largest business,
"It has been a privilege to serve as Broadridge's Chief Financial Officer and contribute to its consistent growth," said
Forward Looking Statements
This press release and other written or oral statements made from time to time by representatives of Broadridge may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical in nature, and which may be identified by the use of words such as "expects," "assumes," "projects," "anticipates," "estimates," "we believe," "could be," "on track," and other words of similar meaning, are forward-looking statements. In particular, statements about our current fiscal year and about our three-year objectives are forward-looking statements.
These statements are based on management's expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed. These risks and uncertainties include those risk factors described and discussed in Part I, "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the year ended
About Broadridge
Broadridge Financial Solutions (NYSE: BR), a global Fintech leader with over
For more information about us, please visit https://www.broadridge.com
Contact information:
Investors
[email protected]
Media
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/broadridge-announces-cfo-transition-302163226.html
SOURCE Broadridge Financial Solutions, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- As Carbon Capture & Storage Gathers Steam, New Consumer Watchdog Report Questions Its Threat To The Public And Lifeline For Fossil Fuels
- Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
- Cash Cat vs AlphaPepe: CASHCAT Reaches $154M Valuation While ALPE Buyers Enter Stage 20 at $0.02551
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share